relugolix
myovant,pfizer
['prostate', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'tps398', 'pfizer']
at asco #gu23 learn about the study design of an ongoing real-world study investigating the safety and effectiveness of a gnrh antagonist in patients with #prostatecancer during routine clinical care tps398 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ